Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers

被引:110
作者
Dershwitz, M
Walsh, JL
Morishige, RJ
Conners, PM
Rubsamen, RM
Shafer, SL
Rosow, CE
机构
[1] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
drug aerosol; pulmonary drug absorption; pulmonary drug delivery;
D O I
10.1097/00000542-200009000-00009
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: A new pulmonary drug delivery system produces aerosols from disposable packets of medication. This study compared the pharmacokinetics and pharmacodynamics of morphine delivered by an AERx prototype with intravenous morphine. Methods: Fifteen healthy volunteers were enrolled. Two subjects were administered four inhalations of 2.2 mg morphine each at 1-min intervals or 4.4 mg over 3 min by intravenous infusion. Thirteen subjects were given twice the above doses, i.e., eight inhalations or 8.8 mg intravenously over 7 min. Arterial blood sampling was performed every minute during administration and at 2, 5, 7, 10, 15, 20, 45, 60, 90, 120, 150, 180, and 240 min after administration. The effect of morphine was assessed by measuring pupil diameter and ventilatory response to a hypercapnic challenge; Pharmacokinetic and pharmacodynamic analyses were performed simultaneously using mixed-effect models, Results: The pharmacokinetic data after intravenous administration were described by a three-exponent decay model preceded by a lag time. The pharmacokinetic model for administration by inhalation consisted of the three-exponent intravenous pharmacokinetic model preceded by a two-exponent absorption model. The authors found that, with administration by inhalation, the total bioavailability was 59%, of which 43% was absorbed almost instantaneously and 57% was absorbed with a half-life of 18 min. The median times to the half-maximal miotic effects of morphine were 10 and 5.5 min after inhalation and intravenous administration, respectively (P < 0.01). The pharmacodynamic parameter k(e0) was approximately 0.003 min(-1). Conclusions: The onset and duration of the effects of morphine are similar after intravenous administration or inhalation via this new pulmonary drug delivery system. Morphine bioavailability after such administration is 59% of the dose loaded into the dosage form.
引用
收藏
页码:619 / 628
页数:10
相关论文
共 20 条
  • [1] BEAL S, 1992, NONMEM USERS GUIDE 5, P48
  • [2] BEAL SL, 1992, NONMEM USERS GUIDE 7, P2
  • [3] Miotic effects of alfentanil and fentanyl occur at very low doses
    Denman, WT
    Rosow, D
    Hennessy, D
    Dershwitz, M
    Rosow, CE
    [J]. ANESTHESIOLOGY, 1997, 87 (03) : A316 - A316
  • [4] Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease
    Dershwitz, M
    Hoke, JF
    Rosow, CE
    Michalowski, P
    Connors, PM
    Muir, KT
    Dienstag, JL
    [J]. ANESTHESIOLOGY, 1996, 84 (04) : 812 - 820
  • [5] THE PHARMACOKINETICS OF THE NEW SHORT-ACTING OPIOID REMIFENTANIL (GI87084B) IN HEALTHY ADULT MALE-VOLUNTEERS
    EGAN, TD
    LEMMENS, HJM
    FISET, P
    HERMANN, DJ
    MUIR, KT
    STANSKI, DR
    SHAFER, SL
    [J]. ANESTHESIOLOGY, 1993, 79 (05) : 881 - 892
  • [6] PHARMACOKINETICS AND PHARMACODYNAMICS OF CODEINE IN END-STAGE RENAL-DISEASE
    GUAY, DRP
    AWNI, WM
    FINDLAY, JWA
    HALSTENSON, CE
    ABRAHAM, PA
    OPSAHL, JA
    JONES, EC
    MATZKE, GR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (01) : 63 - 71
  • [7] MINIMAL COMPARTMENTAL MODEL OF CIRCULATORY MIXING OF INDOCYANINE GREEN
    HENTHORN, TK
    AVRAM, MJ
    KREJCIE, TC
    SHANKS, CA
    ASADA, A
    KACZYNSKI, DA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03): : H903 - H910
  • [8] Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers
    Hoke, JF
    Shlugman, D
    Dershwitz, M
    Michalowski, P
    MalthouseDufore, S
    Connors, PM
    Martel, D
    Rosow, CE
    Muir, KT
    Rubin, N
    Glass, PSA
    [J]. ANESTHESIOLOGY, 1997, 87 (03) : 533 - 541
  • [9] PHARMACOKINETICS OF MORPHINE INJECTED INTRAVENOUSLY INTO THE ANESTHETIZED DOG
    HUG, CC
    MURPHY, MR
    RIGEL, EP
    OLSON, WA
    [J]. ANESTHESIOLOGY, 1981, 54 (01) : 38 - 47
  • [10] PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN DRUG DEVELOPMENT - APPLICATION TO THE INVESTIGATIONAL OPIOID TREFENTANIL
    LEMMENS, HJM
    DYCK, JB
    SHAFER, SL
    STANSKI, DR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (03) : 261 - 271